Matthew Goff Investment Advisor LLC decreased its holdings in shares of iShares US Pharmaceuticals ETF (NYSEARCA:IHE) by 79.2% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,205 shares of the company’s stock after selling 4,577 shares during the quarter. Matthew Goff Investment Advisor LLC’s holdings in iShares US Pharmaceuticals ETF were worth $202,000 as of its most recent SEC filing.

Other hedge funds have also bought and sold shares of the company. Arkansas Financial Group Inc. acquired a new stake in shares of iShares US Pharmaceuticals ETF during the third quarter worth $200,000. Aft Forsyth & Company Inc. acquired a new stake in shares of iShares US Pharmaceuticals ETF during the third quarter worth $212,000. Northeast Financial Consultants Inc acquired a new stake in shares of iShares US Pharmaceuticals ETF during the third quarter worth $231,000. Private Advisor Group LLC acquired a new stake in shares of iShares US Pharmaceuticals ETF during the third quarter worth $237,000. Finally, FMR LLC acquired a new stake in shares of iShares US Pharmaceuticals ETF during the third quarter worth $261,000.

iShares US Pharmaceuticals ETF stock remained flat at $$155.40 during midday trading on Friday. The company had a trading volume of 26,105 shares, compared to its average volume of 18,054. iShares US Pharmaceuticals ETF has a 52-week low of $139.28 and a 52-week high of $170.26.

TRADEMARK VIOLATION WARNING: This piece was first posted by Watch List News and is the property of of Watch List News. If you are accessing this piece on another website, it was copied illegally and reposted in violation of international trademark and copyright laws. The correct version of this piece can be viewed at https://www.watchlistnews.com/matthew-goff-investment-advisor-llc-has-202000-stake-in-ishares-us-pharmaceuticals-etf-ihe/2667371.html.

iShares US Pharmaceuticals ETF Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.

Recommended Story: Understanding debt-to-equity ratio in fundamental analysis

Want to see what other hedge funds are holding IHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares US Pharmaceuticals ETF (NYSEARCA:IHE).

Institutional Ownership by Quarter for iShares US Pharmaceuticals ETF (NYSEARCA:IHE)

Receive News & Ratings for iShares US Pharmaceuticals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares US Pharmaceuticals ETF and related companies with MarketBeat.com's FREE daily email newsletter.